TOTAL VOLUME:

$154.4b

24H VOL:

$290,393,159

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,944,100,805

420,493

Markets across

40,511

events

MATCHED EVENTS:

4,612

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Will CVS Health (CVS) beat quarterly earnings?
⌛Ending Soon
polymarket

Will CVS Health (CVS) beat quarterly earnings?

Oct 26, 2026, 8:01 PM EST - Nov 4, 2026, 9:00 AM EST
Total volume:
$964
Volume 24h:
$607N/A
Liquidity:
$173
15%
Open interest:
$198N/A

Will CVS Health (CVS) beat quarterly earnings?

 - Polymarket

Will CVS Health (CVS) beat quarterly earnings? - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Nov 4, 2026

Time left: 01d:11h:39m

Will CVS Health (CVS) beat quarterly earnings?

74%chance
Amount

$

Trade on
polymarket

Trade on Polymarket

At 92¢ buys you 109 shares | Odds: 74% Total Payout: $109 | Net Profit: $9 Multiplier: 1.09x | ROI: 9% APY not meaningful Low liquidity
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
polymarket

Will CVS Health (CVS) beat quarterly earnings?

Trade
74%
10%
Yes 92¢No 44¢
36¢
$173
$964
170%
N/A
N/A
1d 11h 39m
Active
Total markets: 1

Description

As of market creation, CVS Health is estimated to release earnings on November 4, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.67 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.67 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Polymarket

As of market creation, CVS Health is estimated to release earnings on November 4, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $1.67 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $1.67 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Frequently asked questions

On Polymarket, the dashboard for the CVS earnings market tracks the current odds of CVS Health beating quarterly earnings expectations. It displays the probability assigned to the 'Yes' outcome, reflecting what traders are collectively predicting. You’ll also find a price history chart showing how the market has fluctuated over time, and the 24-hour trading volume, currently at $607. The total volume traded on this market is $964, indicating the level of interest and participation. This provides a real-time view of sentiment surrounding CVS’s financial performance.

Currently, the implied probability of CVS Health beating quarterly earnings, as reflected in this market, is 74.0%. This contrasts with traditional analyst forecasts, which often present a range of expectations. While analysts typically provide point estimates or target ranges, this market aggregates the wisdom of the crowd, offering a continuously updated probability. Discrepancies between this market and analyst predictions can arise from differing information access, biases, or simply the collective insight of traders who are incentivized to accurately forecast the outcome. It's a different way to gauge expectations for CVS’s earnings.

On Polymarket, this market is priced through a continuous auction mechanism. Traders buy and sell shares representing their belief about whether CVS Health will beat quarterly earnings. As more traders buy 'Yes' shares, the price increases, indicating a higher probability. Conversely, increased selling pressure on 'Yes' shares lowers the price. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The price reflects the current consensus view, and the market dynamically adjusts to new information and changing sentiment. This creates a real-time probability assessment based on the collective actions of participants.

This market resolves around Nov 4, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will be based on whether CVS Health’s reported quarterly earnings per share (EPS) exceed the consensus estimate of financial analysts at the time of the earnings release. The final result will be determined by publicly available financial data released by CVS Health and reported by reputable financial news sources. Traders will then be able to claim their winnings based on the outcome.

Several factors could significantly impact this market before it resolves. Unexpected news regarding CVS Health’s performance, such as changes in prescription volume or pharmacy benefit management contracts, could shift trader sentiment. Broader economic indicators, like inflation reports or interest rate decisions, could also influence the market, as they affect consumer spending and healthcare utilization. Additionally, any revisions to analyst earnings estimates for CVS Health will likely be reflected in the price of shares in this market. Finally, company-specific announcements regarding new products or strategic initiatives could also move the market.